» Articles » PMID: 4198200

Immunologic Studies of the Major Nonimmunoglobulin Protein of Amyloid. I. Identification and Partial Characterization of a Related Serum Component

Overview
Journal J Exp Med
Date 1973 Aug 1
PMID 4198200
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Antisera have been prepared against the major nonimmunoglobulin component of secondary and familial Mediterranean fever (FMF) associated amyloid which has been called A component or acid soluble fraction (ASF). The antisera were shown to be monospecific for ASF by precipitation of (125)I-labeled antigen and gave a reaction of identity with four different ASF preparations. The antisera were able to detect a circulating component in human serum that migrated in the alpha1-globulin region. This circulating component gave a line of identity with degraded ASF by double immunodiffusion. 57 normal sera and 89 sera from patients with diseases known to be frequently associated with amyloidosis were tested by immunodiffusion for the circulating ASF component. 7% of normal sera and 50-80% of the pathologic sera had elevated amounts of this component. Absorption studies showed that all normal sera probably have small amounts of this component while cord sera do not have detectable amounts. This component was partially purified and was shown to be slightly larger than albumin. The relation of the circulating component to the acid soluble fraction of amyloid is discussed.

Citing Articles

A preliminary study on effects of storage time and repeated freezing-thawing on the stability of avian serum amyloid A.

Rhim H, Kwag C, Han J Acta Vet Scand. 2024; 66(1):42.

PMID: 39223651 PMC: 11367771. DOI: 10.1186/s13028-024-00764-8.


Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer.

Lee J, Beatty G Cancers (Basel). 2021; 13(13).

PMID: 34202272 PMC: 8267706. DOI: 10.3390/cancers13133179.


Serum Amyloid A3 is required for normal lung development and survival following influenza infection.

Ather J, Dienz O, Boyson J, Anathy V, Amiel E, Poynter M Sci Rep. 2018; 8(1):16571.

PMID: 30410021 PMC: 6224415. DOI: 10.1038/s41598-018-34901-x.


Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.

De Buck M, Gouwy M, Wang J, Van Snick J, Opdenakker G, Struyf S Curr Med Chem. 2016; 23(17):1725-55.

PMID: 27087246 PMC: 5405626. DOI: 10.2174/0929867323666160418114600.


Serum amyloid A1: Structure, function and gene polymorphism.

Sun L, Ye R Gene. 2016; 583(1):48-57.

PMID: 26945629 PMC: 5683722. DOI: 10.1016/j.gene.2016.02.044.


References
1.
BALE W, HELMKAMP R, Davis T, IZZO M, GOODLAND R, Contreras M . High specific activity labeling of protein with I-131 by the iodine monochloride method. Proc Soc Exp Biol Med. 1966; 122(2):407-14. DOI: 10.3181/00379727-122-31148. View

2.
Cathcart E, Skinner M, Cohen A, Lawless O, Benson M . Antigenic determinants in amyloid deposits. Nature. 1970; 228(5276):1090-1. DOI: 10.1038/2281090b0. View

3.
Husby G, Sletten K, Michaelsen T, Natvig J . Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol. 1972; 1(4):393-400. DOI: 10.1111/j.1365-3083.1972.tb03305.x. View

4.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

5.
KUNKEL H . Zone electrophoresis. Methods Biochem Anal. 1954; 1:141-70. DOI: 10.1002/9780470110171.ch6. View